Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8712 |
High Similarity |
NPD6959 |
Discontinued |
0.85 |
High Similarity |
NPD4380 |
Phase 2 |
0.8434 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8393 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8344 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8232 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8182 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8146 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8125 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8118 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8118 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8118 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8081 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8075 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8075 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8061 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7976 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7976 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7963 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7952 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7933 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7907 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7874 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7874 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7862 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7841 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7834 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7829 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7821 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7816 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7811 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7798 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7797 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7791 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7789 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7784 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7764 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7742 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7742 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7742 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7742 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7742 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7742 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7742 |
Intermediate Similarity |
NPD6779 |
Approved |
0.774 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7722 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7714 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7706 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7706 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7692 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7684 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7661 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7654 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7654 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7647 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7647 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7619 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7619 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7607 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7598 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7579 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7579 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7552 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.753 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD37 |
Approved |
0.7515 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7486 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7486 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7474 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7474 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7473 |
Intermediate Similarity |
NPD6534 |
Approved |
0.747 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7447 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7436 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7436 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7432 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7416 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7414 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7399 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7399 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7399 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7382 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7375 |
Intermediate Similarity |
NPD943 |
Approved |
0.7362 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7362 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7337 |
Intermediate Similarity |
NPD920 |
Approved |
0.7321 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7317 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7306 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7306 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7301 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7293 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7289 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7283 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7256 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7256 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7256 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7256 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7251 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7247 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7213 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7195 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7186 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7151 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7126 |
Intermediate Similarity |
NPD1243 |
Approved |
0.712 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7115 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7108 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7105 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7098 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7091 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7065 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7041 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7037 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7022 |
Intermediate Similarity |
NPD919 |
Approved |
0.7 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6973 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.697 |
Remote Similarity |
NPD7584 |
Approved |
0.6959 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6951 |
Remote Similarity |
NPD1613 |
Approved |
0.6951 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD6190 |
Approved |
0.6938 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6938 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6933 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6933 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD1651 |
Approved |
0.6919 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6897 |
Remote Similarity |
NPD7930 |
Approved |
0.6894 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD2798 |
Approved |
0.6893 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6893 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6886 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6879 |
Remote Similarity |
NPD6273 |
Approved |
0.6875 |
Remote Similarity |
NPD1283 |
Approved |
0.6868 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6848 |
Remote Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.6845 |
Remote Similarity |
NPD36 |
Approved |
0.6845 |
Remote Similarity |
NPD4955 |
Approved |
0.6845 |
Remote Similarity |
NPD5028 |
Approved |
0.6845 |
Remote Similarity |
NPD4954 |
Approved |
0.6845 |
Remote Similarity |
NPD5034 |
Approved |
0.6845 |
Remote Similarity |
NPD5026 |
Approved |
0.6845 |
Remote Similarity |
NPD2438 |
Suspended |
0.6833 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6831 |
Remote Similarity |
NPD2403 |
Approved |
0.6829 |
Remote Similarity |
NPD3764 |
Approved |
0.6824 |
Remote Similarity |
NPD2654 |
Approved |
0.6813 |
Remote Similarity |
NPD4749 |
Approved |
0.6809
|
Remote Similarity |
NPD5035 |
Approved |